Literature DB >> 21882186

Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.

Jeremy Setton1, Hiram Cody, Lee Tan, Monica Morrow, Clifford Hudis, Jeffrey Catalano, Beryl McCormick, Simon Powell, Alice Ho.   

Abstract

BACKGROUND: Randomized data suggest that axillary clearance is not necessary in select, clinically lymph node-negative women with positive sentinel lymph node (SLN) biopsies (SLNBs) who undergo breast-conserving surgery or receive whole-breast radiotherapy and systemic therapy. The additional value of axillary radiotherapy in these patients is unknown.
METHODS: The authors identified 326 patients with positive SLNBs who underwent breast-conserving surgery without axillary lymph node dissection from 1997 to 2009. SLN tumor deposits measured ≤0.2 mm in 58% of patients, 0.3 to 2.0 mm in 35% of patients, and >2 mm in 7% Patients. Ninety-three percent of patients received adjuvant radiotherapy. Radiation fields were categorized as standard tangents, high tangents, comprehensive (tangents plus supraclavicular), or partial breast to reflect coverage of the axilla. Standard tangents included both prone and supine positions. Regional failure was defined as recurrence in the ipsilateral supraclavicular, axillary, or internal mammary lymph nodes.
RESULTS: The median follow-up was 55 months (range, 1-158 months). The 4-year rates of regional control, local control, disease-free survival, and overall survival were 99%, 98%, 95%, and 91%, respectively. Three patients had regional recurrences. Two of those patients received adjuvant radiotherapy with standard supine tangents, and 1 patient did not receive radiotherapy. No regional recurrences occurred among 66 patients who received radiotherapy in the prone position.
CONCLUSIONS: Regional control was high (99% at 4 years) in patients who had low-volume SLN disease who did not undergo axillary dissection, regardless of whether the axilla was irradiated. Whole-breast radiation alone, including in the prone position, is sufficient treatment after breast-conserving surgery for select patients with tumor-containing SLNs who omit axillary dissection.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21882186     DOI: 10.1002/cncr.26504

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

Review 1.  Consensus on the regional lymph nodes irradiation in breast cancer.

Authors:  E Bayo; I Herruzo; M Arenas; M Algara
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

2.  Impact of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial on clinical management of the axilla in older breast cancer patients: a SEER-medicare analysis.

Authors:  Holly Caretta-Weyer; Caprice G Greenberg; Lee G Wilke; Jennifer Weiss; Noelle K LoConte; Marquita Decker; Nicole M Steffens; Maureen A Smith; Heather B Neuman
Journal:  Ann Surg Oncol       Date:  2013-12       Impact factor: 5.344

3.  Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial.

Authors:  Lucia Anna Ursini; Marianna Nuzzo; Consuelo Rosa; Marzia Borgia; Luciana Caravatta; Monica Di Tommaso; Marianna Trignani; Fiorella Cristina Di Guglielmo; Giampiero Ausili Cefaro; Domenico Angelucci; Marzia Muzi; Gianluigi Martino; Ettore Cianchetti; Simona Grossi; Saveria Tavoletta; Davide Brocco; Antonino Grassadonia; Nicola Tinari; Simona Gildetti; Nicola D'Ostilio; Liborio Stuppia; Annamaria Porreca; Marta Di Nicola; Domenico Genovesi
Journal:  Strahlenther Onkol       Date:  2022-05-02       Impact factor: 4.033

4.  American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.

Authors:  Abigail S Caudle; Kelly K Hunt; Susan L Tucker; Karen Hoffman; Sarah M Gainer; Anthony Lucci; Henry M Kuerer; Funda Meric-Bernstam; Ruchita Shah; Gildy V Babiera; Aysegul A Sahin; Elizabeth A Mittendorf
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

5.  Bi-tangential hybrid IMRT for sparing the shoulder in whole breast irradiation.

Authors:  P Farace; M A Deidda; I Iamundo de Cumis; I Iamundo de Curtis; E Deiana; R Farigu; G Lay; S Porru
Journal:  Strahlenther Onkol       Date:  2013-10-10       Impact factor: 3.621

6.  Can We Skip Intraoperative Evaluation of Sentinel Lymph Nodes? Nomogram Predicting Involvement of Three or More Axillary Lymph Nodes before Breast Cancer Surgery.

Authors:  Soo Kyung Ahn; Min Kyoon Kim; Jongjin Kim; Eunshin Lee; Tae-Kyung Yoo; Han-Byoel Lee; Young Joon Kang; Jisun Kim; Hyeong-Gon Moon; Jung Min Chang; Nariya Cho; Woo Kyung Moon; In Ae Park; Dong-Young Noh; Wonshik Han
Journal:  Cancer Res Treat       Date:  2017-01-25       Impact factor: 4.679

7.  A Radiation Oncologist's Guide to Axillary Management in Breast Cancer: A Walk Through the Trials.

Authors:  Julie K Jang; Elana R Sverdlik; Naomi R Schechter
Journal:  Curr Breast Cancer Rep       Date:  2019-09-14

8.  SPECT-CT localization of axillary sentinel lymph nodes for radiotherapy of early breast cancer.

Authors:  Sergey Novikov; Pavel Krzhivitskii; Sergey Kanaev; Petr Krivorotko; Nikolay Ilin; Julia Melnik; Nadejda Popova
Journal:  Rep Pract Oncol Radiother       Date:  2019-11-08

9.  Incidental dose distribution to locoregional lymph nodes of breast cancer patients undergoing adjuvant radiotherapy with tomotherapy - is it time to adjust current contouring guidelines to the radiation technique?

Authors:  Michael Mayinger; Kai Joachim Borm; Constantin Dreher; Hendrik Dapper; Marciana-Nona Duma; Markus Oechsner; Severin Kampfer; Stephanie Elisabeth Combs; Daniel Habermehl
Journal:  Radiat Oncol       Date:  2019-08-01       Impact factor: 3.481

10.  OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.

Authors:  Manuel Algara López; Elvira Rodríguez García; Inmaculada Beato Tortajada; Francisco José Martínez Arcelus; Juan Salinas Ramos; José Reyes Rodríguez Garrido; Xavier Sanz Latiesas; Ana Soler Rodríguez; Germán Juan Rijo; Amanda Flaquer García
Journal:  Radiat Oncol       Date:  2020-10-02       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.